Department Of Chemotherapy 1

1. Assessment of safety and tolerability of subcutaneous trastuzumab in patients with HER2-positive early breast cancer: Results of an open-label, randomized, multicenter, phase IIIB ESCAPE trial
2. Association of Gene Polymorphisms with Breast Cancer Risk in the Kazakh Population
3. Effects of metastatic CRC predictors on treatment outcomes
1